Compare Definium Therapeutics Inc. Common Shares (DFTX) vs EPR Properties (EPR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Definium Therapeutics Inc. Common Shares vs EPR Properties — how do they compare? Definium Therapeutics Inc. Common Shares trades at $34.01 (market cap $4.71B), while EPR Properties trades at $54.87 (market cap $4.14B). The key difference: Definium Therapeutics Inc. Common Shares and EPR Properties are close in size by market cap, and EPR Properties pays a 6.88% dividend while Definium Therapeutics Inc. Common Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and EPR Properties for 45 Days on average.
| DFTX | EPR | |
|---|---|---|
Market Cap | $4.71B | $4.14B |
Volume | 1,966,636 | 874,621 |
Sector | Health | Real Estate |
52-Week High | $48.45 | $64.32 |
52-Week Low | $10.68 | $48.71 |
Typical Hold Time | 0 Days | 45 Days |
Enterprise Value | $3.67B | $7.65B |
Dividend Yield | — | 6.88% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
EPR Properties trades at $54.08, down 2.15% on the day, with a bearish technical signal. The REIT maintains strong fundamentals, including a 91.41% gross margin and a 37.66% net income margin, though net income is projected to dip slightly in 2026. Recent news highlights its focus on monthly dividends and diversification beyond theaters into experiential properties.
The outlook is mixed; analyst consensus is a 'Buy' with a $65.50 price target, suggesting significant upside, but technical indicators and a recent earnings miss signal near-term caution. Key risks include exposure to interest rate sensitivity and execution of its diversification strategy amidst a bearish market sentiment.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Definium Therapeutics Inc. Common Shares
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →About EPR Properties
EPR Properties is a REIT specializing in experiential real estate, including movie theaters and leisure destinations like ski resorts and water parks across the US and Canada.
Read more on EPR →
